Oramed Pharmaceuticals appoints Avraham Gabay as CFO effective June 18, 2024

ORAMED PHARMACEUTICALS INC.

Avraham Gabay appointed CFO, Treasurer, and Secretary, effective June 18, 2024.
Gabay previously served as interim CFO of BiomX Inc. (NYSE American: PHGE) since 2023.
He served as CFO of Oramed from 2019-2021 and as CFO of its 63% subsidiary Oravax Inc. from 2021-2023.
Compensation: gross monthly salary NIS 68,000, company car, eligibility for bonuses and equity at board discretion.
Gabay holds law and accounting degree from Tel-Aviv University, is a CPA in Israel and member of Israeli Bar.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Avraham Gabay

Chief Financial Officer, Treasurer and Secretary

ORMP · ORAMED PHARMACEUTICALS INC.

Effective: 2024-06-18
Filed: June 10, 2024, 7:59 PM ET

On June 6, 2024, Oramed Pharmaceuticals Inc. (the “Company”) appointed Mr. Avraham Gabay to serve as the Chief Financial Officer, Treasurer and Secretary of the Company, effective as of June 18, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Avraham Gabay was appointed as Chief Financial Officer, Treasurer and Secretary at ORAMED PHARMACEUTICALS INC..

Action: appointed
Role: Chief Financial Officer, Treasurer and Secretary

Exact text from the filing

On June 6, 2024, Oramed Pharmaceuticals Inc. (the “Company”) appointed Mr. Avraham Gabay to serve as the Chief Financial Officer, Treasurer and Secretary of the Company, effective as of June 18, 2024.

View on SEC.gov

ORAMED PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-051355

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.